Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eli Lilly Cdr [Cad Hedged] (LLY.NE)

Eli Lilly Cdr [Cad Hedged] (LLY.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eli Lilly Cdr [Cad Hedged] Lilly Corporate Center Indianapolis IN 46285 USA

P: 317-276-2000

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Key Statistics

Overview:

Market Capitalization, $K 1,309,079,669
Shares Outstanding, K 32,810,951
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 45,043 M
Annual Net Income, $ 10,590 M
Last Quarter Sales, $ 17,601 M
Last Quarter Net Income, $ 5,583 M

Growth:

1-Year Return 34.74%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 15.08%
5-Year Earnings Growth 5.67%

Per-Share Information:

Most Recent Earnings 0.17 on 10/30/25
Next Earnings Date N/A
Earnings Per Share ttm 0.56
EPS Growth vs. Prev Qtr -1.27%
EPS Growth vs. Prev Year 1.02%
Annual Dividend & Yield (Paid) 0.15 (0.57%)
Annual Dividend & Yield (Fwd) 0.25 (0.57%)
Most Recent Dividend 0.063 on 02/13/26
Next Ex-Dividends Date 02/13/26
Dividend Payable Date 03/17/26
Dividend Payout Ratio 27.52%

LLY.NE Ratios

Ratio
Price/Earnings ttm 49.47
Price/Earnings forward 31.75
Price/Earnings to Growth 0.95
Return-on-Equity % 96.82%
Return-on-Assets % 19.33%
Profit Margin % 23.51%
Debt/Equity 2.01
Price/Sales 15.30
Price/Book 37.98
Book Value/Share 1.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar